Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care

Nicotinic Acid, Alone and in Combinations, for Reduction of Cardiovascular Risk

(2008) B. Greg Brown et al.   AMERICAN JOURNAL OF CARDIOLOGY

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events

(2008) Samia Mora et al.   CIRCULATION

Dosage, titration, and gaps in treatment with extended release niacin in clinical practice

(2008) Sachin J. Kamal-Bahl et al.   CURRENT MEDICAL RESEARCH AND OPINION

Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy

(2008) Jonathan Belsey et al.   CURRENT MEDICAL RESEARCH AND OPINION

Nicotinic acid: recent developments

(2008) Vaijinath S Kamanna et al.   CURRENT OPINION IN CARDIOLOGY

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

(2008) Jean-Charles Fruchart et al.   Diabetes & Vascular Disease Research

Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire©: results from a randomised placebo-controlled clinical trial

(2008) J. F. Paolini et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia

(2008) D. Maccubbin et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments

(2008) Edward J. Mills et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein Management in Patients With Cardiometabolic Risk

(2008) John D. Brunzell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY